The Relative Strength (RS) Rating for Axsome Therapeutics jumped into a new percentile Wednesday, with an increase from 72 to 81.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This unique rating tracks technical performance by showing how a stock's price action over the last 52 weeks compares to that of other stocks on the major indexes.
Decades of market research shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Axsome Therapeutics is trying to complete a consolidation with a 91.29 entry. It rebounded above the 200-day moving average and is now trying to clear the rest. If the stock does that, then let's see if it can break out in heavy trading and clear the pivot.
The company posted 0% earnings growth in the latest quarterly report. Sales increased 429%.
Axsome Therapeutics holds the No. 156 rank among its peers in the Medical-Biomed/Biotech industry group. Amphastar Pharm and HUTCHMED (China) ADR are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
